Regulatory Warning Letters Related to Poor Real-Time Stability Practices
Regulatory Warning Letters Related to Poor Real-Time Stability Practices Common Regulatory Warning Letters for Deficiencies in Real-Time Stability Testing Real-time stability testing is a cornerstone of pharmaceutical product quality assurance. It substantiates a drug’s shelf life and confirms that the product maintains its intended efficacy, safety, and quality under recommended storage conditions. However, numerous FDA…
Read More “Regulatory Warning Letters Related to Poor Real-Time Stability Practices” »